07:00 , Aug 18, 2014 |  BC Week In Review  |  Financial News

Aoxing financial update

Aoxing Pharmaceutical Co. Inc. (NYSE-M:AXN), Shijiazhuang, China   Business: Neurology   Date announced: 2014-08-06   Note: Aoxing said NYSE MKT granted the company an extension until Sept. 21 to regain compliance with the requirement that...
07:00 , Jun 23, 2014 |  BC Week In Review  |  Financial News

Aoxing Pharmaceutical Co. Inc financial update

Aoxing Pharmaceutical Co. Inc . (NYSE-M:AXN), Shijiazhuang, China   Business: Neurology   Date announced: 2014-06-16   Note: Aoxing said NYSE MKT granted the company an extension until June 30 to regain compliance with the requirement...
07:00 , Mar 17, 2014 |  BC Week In Review  |  Financial News

Aoxing financial update

Aoxing said NYSE MKT granted the company an extension until May 30 to regain compliance with the requirement that applies if a company has sustained losses that are so substantial in relation to its overall...
08:00 , Dec 9, 2013 |  BC Week In Review  |  Financial News

Aoxing financial update

Aoxing said NYSE MKT granted the company an extension until March 1, 2014, to regain compliance with the requirement that applies if a company has sustained losses that are so substantial in relation to its...
08:00 , Nov 25, 2013 |  BC Week In Review  |  Financial News

Aoxing financial update

Aoxing disclosed in its earnings for the fiscal quarter ended Sept. 30 that it extended the maturity date of its $3.2 million loan from SJZ Construction Investment to Nov. 11, 2014, from Nov. 3, 2013....
08:00 , Nov 11, 2013 |  BC Week In Review  |  Financial News

Aoxing financial update

Aoxing received notice from NYSE MKT that the company is not in compliance with two minimum requirements for continued listing. The company has until Nov. 8 to submit a plan to regain compliance with the...
07:00 , Jul 16, 2012 |  BC Week In Review  |  Company News

Aoxing management update

Aoxing Pharmaceutical Co. Inc. (NYSE-M:AXN), Shijiazhuang, China   Business: Neurology   Resigned: Bob Yunjun Ai as CFO; SVP of Finance Guoan Zhang becomes interim CFO  ...
07:00 , Jul 2, 2012 |  BC Week In Review  |  Clinical News

MoxDuo IR morphine/oxycodone regulatory update

QRxPharma said it received a complete response letter from FDA for an NDA for MoxDuo IR morphine/oxycodone to treat moderate to severe acute pain. The company said the agency requested clarity on the product's safety...
08:00 , Dec 12, 2011 |  BC Week In Review  |  Financial News

Aoxing completes debt financing

Aoxing Pharmaceutical Co. Inc. (NYSE-A:AXN), Shijiazhuang, China   Business: Neurology   Date completed: 12/7/11   Type: Debt financing   Raised: RMB20 million ($3.2 million)   Investors: Shijiazhuang Construction Investment; China Construction Bank   Note: The...
08:00 , Nov 14, 2011 |  BC Week In Review  |  Clinical News

MoxDuo IR morphine/oxycodone regulatory update

FDA accepted for review an NDA submitted by QRxPharma for MoxDuo IR morphine/oxycodone to treat moderate to severe acute pain. The PDUFA date is June 25, 2012. The company submitted the NDA under section 505(b)(2)...